Evidence map›Paper›PMID 40183656›Full record

ArticleInfection & chemotherapy2025

Genetic Determinants of Carbapenem and Fluoroquinolone Resistance in

Simbiat Tolani Lawal, Fadilulahi Ayokunle Usman, Zainab Adepeju Adams, Omoladun Safurat Ogunbayo, Chioma Margaret Ekwedigwe, Rukayat Olajumoke Jimoh, Fortunate Opeyemi Oladeru, Oyindamola Osho, Utibeima Udo Essiet, Abraham Ajayi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection & chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Simbiat Tolani LawalMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-8856-3881
Fadilulahi Ayokunle UsmanMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0002-4907-7979
Zainab Adepeju AdamsMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0009-0003-1549-4912
Omoladun Safurat OgunbayoMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0009-0003-6623-5988
Chioma Margaret EkwedigweBiochemistry and Nutrition Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0009-0004-1136-9476
Rukayat Olajumoke JimohBiochemistry and Nutrition Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0009-0009-3949-5614
Fortunate Opeyemi OladeruMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0009-0009-7778-4484
Oyindamola OshoMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0009-0002-5883-0595
Utibeima Udo EssietMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0003-0422-8689
Abraham AjayiMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0001-6681-1795
Stella SmithMolecular Biology and Biotechnology Department, Nigerian Institute of Medical Research (NIMR), Yaba, Lagos State, Nigeria.ORCID https://orcid.org/0000-0003-2163-1189

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance has emerged as a global public health challenge, leading to higher mortality rates from infections that were once treatable with antibiotics. In this study, we assessed the susceptibility of MATERIALS AND

methodsThis retrospective study included 46

resultsThe

conclusionThis study revealed a high level of resistance to fluoroquinolones, emphasizing the need for judicious use of antibiotics, particularly those with low resistance rates. Continuous surveillance is essential to monitor emerging trends in resistance among bacterial pathogens.

Indexed as

Antibiotic resistanceCarbapenemEscherichia coliFluoroquinolonePlasmid

Identifiers

PMID40183656
PMCPMC11972918

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.